Found 5 matching trials
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer PHASE3 The purpose of this research study is to evaluate the progression-free surv...
Show More Location
University of Alabama at Birmingham, Comprehensive Cancer Center
Learn More & Join Trial
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer PHASE3 Bone metastases and associated pain are a major cause of morbidity and mort...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma PHASE3 This is a multicenter, randomized, double-blinded, controlled Phase 3 trial...
Show More Status
Active Not Recruiting
Location
Exelixis Clinical Site #116
Learn More & Join Trial
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 PHASE3 This study will evaluate the effect of cabozantinib compared to prednisone ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib PHASE3 The purpose of this study is to evaluate the effect of Cabozantinib (XL184)...
Show More Location
Multiple Locations
Learn More & Join Trial